Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Merck and Pfizer provide update on avelumab in platinum-resistant/refractory ovarian cancer

worldpharmanewsNovember 21, 2018

Tag: Merck , avelumab , ovarian cancer , Pfizer

PharmaSources Customer Service